# Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis

> **NCT03529136** · PHASE2 · UNKNOWN · sponsor: **Shandong Qilu Stem Cells Engineering Co., Ltd.** · enrollment: 252 (estimated)

## Conditions studied

- Decompensated Liver Cirrhosis

## Interventions

- **BIOLOGICAL:** UC-MSC

## Key facts

- **NCT ID:** NCT03529136
- **Lead sponsor:** Shandong Qilu Stem Cells Engineering Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-04-30
- **Target enrollment:** 252 (ESTIMATED)
- **Last updated:** 2018-05-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03529136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03529136, "Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03529136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*